Published in J Clin Invest on December 01, 1978
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med (1983) 4.89
The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A (1982) 4.65
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2011) 3.23
Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest (1981) 2.24
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest (1982) 2.12
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest (1980) 2.07
Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen. J Exp Med (1982) 2.00
A monoclonal antibody to brush border and passive Heymann nephritis. Clin Exp Immunol (1984) 1.74
Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol (2012) 1.69
Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol (2012) 1.57
gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc Natl Acad Sci U S A (1992) 1.55
Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. I. Renal distribution. Am J Pathol (1986) 1.53
Production and characterization of monoclonal antibodies against rat brush border antigens of the proximal convoluted tubule. Immunology (1984) 1.42
Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.40
Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One (2013) 1.37
Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest (1986) 1.35
Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol (1987) 1.33
Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.33
Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol (2013) 1.31
Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci U S A (1993) 1.29
Glomerulonephritis induced in the rabbit by antiendothelial antibodies. J Clin Invest (1987) 1.25
Treatment of idiopathic membranous nephropathy. J Am Soc Nephrol (2012) 1.21
The pathogenetic role of free-circulating antibody in autologous immune complex glomerulonephritis. Clin Exp Immunol (1980) 1.21
Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol (2005) 1.19
Passive Heymann's nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins. Clin Exp Immunol (1980) 1.15
An active model of immune complex glomerulonephritis in the rat employing cationized antigen. Am J Pathol (1983) 1.08
Study of circulating immune complex size in systemic lupus erythematosus. Clin Exp Immunol (1981) 1.08
Membrane attack complex deposition in experimental glomerular injury. Am J Pathol (1985) 1.07
Membranous nephropathy: from models to man. J Clin Invest (2014) 1.05
Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes. Clin Exp Immunol (1983) 1.04
Nature of the glomerular capillary injury in human membranous glomerulopathy. J Clin Invest (1986) 1.02
Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. Semin Immunopathol (2007) 1.02
Idiopathic membranous nephropathy: an autoimmune disease. Semin Nephrol (2011) 1.02
Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis. J Exp Med (1986) 1.02
Polyvalent antigen-antibody interactions are required for the formation of electron-dense immune deposits in passive Heymann's nephritis. Am J Pathol (1986) 1.01
Nondissociating cationic immune complexes can deposit in glomerular basement membrane. J Exp Med (1983) 1.01
Cellular immunity in glomerulonephritis. Am J Pathol (1982) 0.99
Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol (1989) 0.97
Comparison of antigenic targets involved in antibody-mediated membranous glomerulonephritis in the mouse and rat. Am J Pathol (1985) 0.96
Nephrotic syndrome. West J Med (1982) 0.96
Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV. Clin Exp Immunol (1987) 0.94
Immunopathogenesis of membranous nephropathy: an update. Semin Immunopathol (2014) 0.94
An overview of molecular mechanism of nephrotic syndrome. Int J Nephrol (2012) 0.93
Diminished synthesis of immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous glomerulonephropathy. J Clin Invest (1980) 0.93
Passive Heymann nephritis in the rat produced by a heterologous antibody to a heterologous kidney fraction 3 antigen. Br J Exp Pathol (1982) 0.93
The role of complement in membranous nephropathy. Semin Nephrol (2013) 0.90
In vivo interaction of antibodies with cell surface antigens. A mechanism responsible for in situ formation of immune deposits in the zona pellucida of rabbit oocytes. J Clin Invest (1985) 0.90
Antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with dextran-anti-dextran immune complexes. Am J Pathol (1983) 0.88
Monoclonal anti-DNA antibodies: an approach to studying SLE nephritis. Clin Exp Immunol (1985) 0.88
Monoclonal antibodies to rat renal antigens. Immunology (1984) 0.87
Infection and glomerulonephritis. Semin Immunopathol (2007) 0.87
Passive Heymann-like nephritis in the rabbit. Br J Exp Pathol (1985) 0.87
Circulatory antigen of Heymann nephritis. II. Isolation of a 70,000 MW antigen from normal rat serum which cross-reacts with Heymann nephritis antigen. Immunology (1986) 0.86
Studies with antibodies to cultured rat glomerular epithelial cells. Subepithelial immune deposit formation after in vivo injection. Am J Pathol (1989) 0.86
Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats. Am J Pathol (1989) 0.86
Role of antigenic charge and antibody avidity on the glomerular immune complex localization in serum sickness of mice. Clin Exp Immunol (1986) 0.85
Immune-complex nephritis in the rabbit produced by injections of rat renal tubular fraction 3 antigen. Br J Exp Pathol (1981) 0.84
The effect of pre-injection of rat kidney F3 antigen on the development of passive Heymann nephritis. Br J Exp Pathol (1983) 0.84
Membranous nephropathy: not just a disease for adults. Pediatr Nephrol (2013) 0.84
Enhancement of in situ immune complex formation in isolated perfused kidneys in Heymann's nephritis. Clin Exp Immunol (1982) 0.83
Membranous nephropathy. Insights from Heymann nephritis. Am J Pathol (1994) 0.83
Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis. Am J Pathol (1996) 0.82
New ideas in the pathogenesis of nephritis. J Clin Pathol (1981) 0.82
Production of a new model of slowly progressive Heymann nephritis. Int J Exp Pathol (2003) 0.81
A search for circulating immune complex-like material during the course of autoimmune complex glomerulonephritis in Lewis and Brown Norway rats. Clin Exp Immunol (1980) 0.81
Membranous Nephropathy: A Journey From Bench to Bedside. Am J Kidney Dis (2016) 0.81
Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats. Int J Exp Pathol (2004) 0.80
Mouse models of membranous nephropathy: the road less travelled by. Am J Clin Exp Immunol (2013) 0.80
Intraglomerular basement membrane translocation of immune complex (IC) in the development of passive in situ IC nephritis of rats. Am J Pathol (1993) 0.80
Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells. Clin Exp Immunol (1993) 0.79
Rat bovine serum albumin (BSA) nephritis. VI. The influence of chemically altered antigen. Clin Exp Immunol (1986) 0.79
Progressive passive Heymann nephritis: induction of autologous antibodies to rat brush border by multiple injections of heterologous antiserum. Clin Exp Immunol (1985) 0.79
Free intraglomerular malarial antigens. Br J Exp Pathol (1985) 0.78
A simple technique for detecting the antigen of Heymann nephritis in glomeruli by immunofluorescence. Clin Exp Immunol (1986) 0.78
Anti-Fx1A induces association of Heymann nephritis antigens with microfilaments of cultured glomerular visceral epithelial cells. Am J Pathol (1987) 0.78
Novel targets for immunotherapy in glomerulonephritis. Biologics (2008) 0.77
Genetic factors influence level of proteinuria in cationic antigen-induced immune complex glomerulonephritis in the rat. Clin Exp Immunol (1985) 0.77
Ten-year advances in immunopathology of glomerulonephritis: translated into patients' care or lost in translation? Semin Immunopathol (2014) 0.76
A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen. Clin Exp Immunol (1994) 0.76
High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus. Am J Nephrol (2015) 0.76
Cationised IgM rheumatoid factor: in-vivo glomerular localization and immunoabsorptive capacity in the mouse. Clin Exp Immunol (1985) 0.76
Circulatory antigen of Heymann nephritis. III. Presence of the 70-kD circulatory protein in the immune deposits of Heymann nephritis. Clin Exp Immunol (1991) 0.76
Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities. Clin Exp Immunol (1987) 0.76
Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats. Clin Exp Immunol (1983) 0.75
Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes. Int J Exp Pathol (2011) 0.75
Balancing cancer risk and efficacy of using cyclophosphamide to treat idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2014) 0.75
A new experimental model of in-situ immune complex disease of the lung. Clin Exp Immunol (1988) 0.75
Tubular antigen-associated renal disease in New Zealand white rabbits. Clin Exp Immunol (1986) 0.75
Proteinuria induced by anti-dipeptidyl peptidase IV (gp108); role of circulating and glomerular antigen. Clin Exp Immunol (1994) 0.75
2015 Homer W. Smith Award: The Podocyte from Periphery to Center Stage. J Am Soc Nephrol (2016) 0.75
PLA2R and THSD7A: Disparate Paths to the Same Disease? J Am Soc Nephrol (2017) 0.75
A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease. Pflugers Arch (2017) 0.75
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY. Virology (1963) 8.83
Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med (1959) 7.22
Immune complex disease in experimental animals and man. Adv Immunol (1973) 5.30
Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest (1978) 4.83
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med (1968) 4.29
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
Studies on the renal glomerular basement membrane. Preparation and chemical composition. J Biol Chem (1967) 3.76
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. J Cell Biol (1975) 3.04
Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest (1977) 2.82
Metabolic activities of the isolated perfused rat kidney. Biochem J (1967) 2.41
Human glomerular basement membrane. Preparation and composition. Biochemistry (1970) 2.26
Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proc Natl Acad Sci U S A (1976) 2.18
Induction of an autologous immune-complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody. I. Production of chronic progressive immune-complex glomerulonephritis. Br J Exp Pathol (1974) 2.09
Diagnosis of immunopathologic renal disease. Kidney Int (1974) 2.07
Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus. Lab Invest (1978) 1.89
Distribution of endogenous albumin in the rat glomerulus: role of hemodynamic factors in glomerular barrier function. Kidney Int (1976) 1.88
The pathogenesis of experimental membranous glomerulonephritis induced with homologous nephritogenic tubular antigen. J Exp Med (1976) 1.87
Sodium reabsorption in the perfused rat kidney. Am J Physiol (1973) 1.82
Experimental autoimmune nephrosis in rats. Morphogenesis of the glomerular lesion: immunohistochemical and electron microscopic studies. Am J Pathol (1969) 1.81
Immune complex orchitis in vasectomized rabbits. J Exp Med (1976) 1.79
Detection of circulating immune complexes in patients with glomerulonephritis. Kidney Int (1977) 1.66
Studies on passive serum sickness. I. The glomerular fine structure of serum sickness nephritis induced by preformed antigen-antibody complexes in the mouse. Lab Invest (1971) 1.63
Demonstration of an antibody to proximal tubular antigen in the pathogenesis of experimental autoimmune nephrosis in rats. J Lab Clin Med (1969) 1.55
Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. IV. Investigations into the pathogenesis of the model. Lab Invest (1978) 1.52
Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis. J Clin Invest (1978) 1.50
Mechanisms involved in the deposition of immune complexes in tissues. J Exp Med (1971) 1.49
Interstitial immune complex thyroiditis in mice: the role of autoantibody to thyroglobulin. J Exp Med (1974) 1.49
Chronic nephritis induced by antibodies reacting with glomerular-bound immune complexes. Kidney Int (1977) 1.32
Glomerular permeability to proteins. Effects of hemodynamic factors on the distribution of endogenous immunoglobulin G and exogenous catalase in the rat glomerulus. Lab Invest (1976) 1.31
Nonglomerular renal disease produced in rabbits by immunization with homologous kidney. Am J Pathol (1971) 1.19
Experimental glomerulonephritis in the mouse associated with mesangial deposition ofautologous ferritin immune complexes. Lab Invest (1975) 1.19
Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein. Lab Invest (1976) 1.13
Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. J Clin Invest (1978) 1.08
Nephron function of the isolated perfused rat kidney. Am J Physiol (1976) 1.06
Membranous glomerulonephritis: current status. Hum Pathol (1971) 1.05
Nephritogenic glycoprotein. II. Experimental production of membranous glomerulonephritis in rats by a single injection of homologous renal glycopeptide. Lab Invest (1972) 1.04
The ultrastructure of the glomerular slit diaphragm in autologous immune complex nephritis. Lab Invest (1976) 1.03
Determinants of the transglomerular passage of macromolecules. Fed Proc (1977) 1.01
Complement-independent nephrotoxic nephritis in the guinea pig. Kidney Int (1977) 1.01
Relationship of levels of circulating immune complexes to histologic patterns of nephritis: a comparative study of membranous glomerulonephropathy and diffuse proliferative glomerulonephritis. J Lab Clin Med (1977) 1.01
Altered functional properties of the renal glomerulus in autologous immune complex nephritis: an ultrastructural tracer study. J Exp Med (1974) 1.01
FUNCTIONAL EVALUATION OF ISOLATED PERFUSED RAT KIDNEY. J Appl Physiol (1963) 0.93
Immune complex infusion in the rat. Renal functional and morphological changes. Clin Exp Immunol (1976) 0.90
The isolated perfused kidney: possibilities, limitations and results. Kidney Int (1975) 0.89
In situ immune complex formation and glomerular injury. Kidney Int (1980) 3.52
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest (1980) 2.07
A dangerous error in the dilution of 25 percent albumin. N Engl J Med (1998) 2.04
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet (1976) 1.96
Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int (1985) 1.67
Experimental glomerulonephritis. Methods Enzymol (1988) 1.67
Mechanisms of glomerular injury in immune-complex disease. Kidney Int (1985) 1.64
Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int (1999) 1.62
Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (1991) 1.61
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney Int (1999) 1.57
Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int (2000) 1.47
Crescentic glomerulonephritis without immune deposits: clinicopathologic features. Kidney Int (1979) 1.45
The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol (1992) 1.44
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int (1996) 1.43
Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest (1986) 1.42
Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol (1995) 1.41
Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int (1995) 1.41
SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. J Biol Chem (1999) 1.40
Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int (1991) 1.39
Acute renal failure due to lymphomatous infiltration of the kidneys. J Am Soc Nephrol (1997) 1.36
The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med (1988) 1.35
Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest (1986) 1.35
Granulomatous prostatitis following bacillus Calmette-Guerin immunotherapy of bladder cancer. J Urol (1988) 1.35
Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int (1998) 1.33
Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest (1999) 1.33
Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.33
Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol (1998) 1.32
Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest (2001) 1.31
Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol (1993) 1.30
The use of single pediatric cadaver kidneys for transplantation. Transplantation (1988) 1.29
Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int (1990) 1.28
Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis. Am J Med (1979) 1.27
Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest (1992) 1.26
Perforation of the colon in renal homograft recipients. A report of 11 cases and a review of the literature. Ann Surg (1986) 1.26
Vertebral osteomyelitis and aortic lesions: case report and review. Rev Infect Dis (1992) 1.26
Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med (1974) 1.24
Decay accelerating factor regulates complement activation on glomerular epithelial cells. J Immunol (1989) 1.24
Detection of terminal complement components in experimental immune glomerular injury. Kidney Int (1984) 1.24
Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum. Kidney Int (2001) 1.23
Idiopathic rapidly progressive glomerulonephritis. Am J Nephrol (1982) 1.23
Landry-Guillain-Barré-Strohl syndrome and immune-complex nephritis. Lancet (1973) 1.22
Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus. J Clin Invest (1997) 1.21
Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol (1989) 1.21
Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest (1988) 1.20
Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest (1995) 1.20
Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil. Lab Invest (1988) 1.20
The effect of bile acids and renal ischemia on renal function. J Lab Clin Med (1968) 1.19
Experimental glomerulonephritis in the mouse associated with mesangial deposition ofautologous ferritin immune complexes. Lab Invest (1975) 1.19
Phospholipid metabolism in the initiation of renal compensatory growth after acute reduction of renal mass. J Clin Invest (1974) 1.18
Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol (1999) 1.18
Studies of progressive glomerular sclerosis in the rat. Am J Pathol (1986) 1.18
Mesangial lesions and focal glomerular sclerosis in the aging rat. Lab Invest (1975) 1.17
Experimental glomerulonephritis in the guinea pig. I. Glomerular lesions associated with antiglomerular basement membrane antibody deposits. Lab Invest (1973) 1.16
Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest (1992) 1.15
Specific uptake of Heymann's nephritic kidney eluate by rat kidney: studies in vivo and in isolated perfused kidneys. Lab Invest (1982) 1.15
Pericarditis following renal transplantation. Transplantation (1991) 1.15
Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int (1997) 1.14
Occupational solvent exposure and glomerulonephritis. A case report and review of the literature. JAMA (1988) 1.14
Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int (1994) 1.14
Autologous immune complex nephropathy. I. Sequential study of immune complex deposition, ultrastructural changes, proteinuria, and alterations in glomerular sialoprotein. Lab Invest (1976) 1.13
Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis. Kidney Int (1985) 1.13
Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int (1997) 1.11
Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant (1998) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis. Kidney Int (1987) 1.09
Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. J Clin Invest (1978) 1.08
Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis. Circ Res (1987) 1.08
Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation (1990) 1.08
Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol (1997) 1.08
Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int (1995) 1.07
Membrane attack complex deposition in experimental glomerular injury. Am J Pathol (1985) 1.07
Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol (1992) 1.07
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol (1993) 1.06
A new model of renal microvascular endothelial injury. Kidney Int (1997) 1.06
Developmental expression of the nephritogenic antigen of monoclonal antibody 5-1-6. Am J Pathol (1995) 1.06
Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest (1996) 1.06
Mechanisms and consequences of proteinuria. Lab Invest (1986) 1.05
Anti-Fx1A produces complement-dependent cytotoxicity of glomerular epithelial cells. Kidney Int (1988) 1.05